Currently out of the existing stock ratings of Jack Allen, 12 are a HOLD (34.29%), 23 are a BUY (65.71%).

Jack Allen

Work Performance Price Targets & Ratings Chart

Analyst Jack Allen works at BAIRD with a stock forecast success ratio of 48.33% fulfilled within 27.47 days on average.

Jack Allen’s has documented 68 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BLUE, Bluebird bio at 12-Dec-2023.

Wall Street Analyst Jack Allen

Analyst best performing recommendations are on TIL (INSTIL BIO .).
The best stock recommendation documented was for TIL (INSTIL BIO .) at 12/9/2022. The price target of $14 was fulfilled within 4 days with a profit of $5.15 (26.89%) receiving and performance score of 67.23.

Average potential price target upside

ALLO Allogene Therapeutics CLLS Cellectis SA DBTX Decibel Therapeutics FATE Fate Therapeutics INKT Mink Therapeutics TIL Instil Bio . TSHA Taysha Gene Therapies  VOR Vor Biopharma VYGR Voyager Therapeutics FREQ Frequency Therapeutics ACLX Arcellx CRSP Crispr Therapeutics AG RCOR Renovacor NTLA Intellia Therapeutics BLUE Bluebird bio

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$2.88 (56.25%)

20

3 days ago

0/2 (0%)

$2.86 (55.64%)

Buy

10

$4.88 (95.31%)

12

1 months 11 days ago

1/7 (14.29%)

$6.91 (223.62%)

28

Buy

10

$4.88 (95.31%)

12

1 months 11 days ago

0/5 (0%)

$6.91 (223.62%)

Buy

18

1 months 22 days ago

2/9 (22.22%)

$12.2 (210.34%)

94

Hold

35

1 months 25 days ago

1/2 (50%)

$19.71 (128.91%)

6

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jack Allen is most bullish on?

Potential upside of $8.61 has been obtained for BLUE (BLUEBIRD BIO)

Which stock is Jack Allen is most reserved on?

Potential downside of $0.2 has been obtained for FREQ (FREQUENCY THERAPEUTICS)

What Year was the first public recommendation made by Jack Allen?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?